Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Entinostat by Taizhou Yiteng Jingang Pharmaceutical for T-Cell Lymphomas: Likelihood of Approval
Entinostat is under clinical development by Taizhou Yiteng Jingang Pharmaceutical and currently in Phase II for T-Cell Lymphomas. According to...
Entinostat by Taizhou Yiteng Jingang Pharmaceutical for Unspecified B-Cell Lymphomas: Likelihood of Approval
Entinostat is under clinical development by Taizhou Yiteng Jingang Pharmaceutical and currently in Phase II for Unspecified B-Cell Lymphomas. According...
Entinostat by Taizhou Yiteng Jingang Pharmaceutical for Solid Tumor: Likelihood of Approval
Entinostat is under clinical development by Taizhou Yiteng Jingang Pharmaceutical and currently in Phase II for Solid Tumor. According to...